Ikarian Capital, LLC is a New York-based global investment management firm registered as an Investment Adviser with the U.S. Securities and Exchange Commission (SEC). The firm primarily employs a fundamental, long/short equity strategy, with a specialized focus on investment opportunities within the global biotechnology and pharmaceutical industries. Ikarian Capital manages private investment funds (hedge funds) for its clients, leveraging deep scientific and financial analysis to inform its investment decisions.

Founded in

United States